Edition:
India

Deciphera Pharmaceuticals Inc (DCPH.OQ)

DCPH.OQ on NASDAQ Stock Exchange Global Select Market

23.45USD
18 Apr 2019
Change (% chg)

$0.48 (+2.09%)
Prev Close
$22.97
Open
$22.95
Day's High
$23.52
Day's Low
$22.27
Volume
72,641
Avg. Vol
74,729
52-wk High
$45.61
52-wk Low
$18.56

About

Deciphera Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is developing drugs to improve the lives of cancer patients. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib. Its proprietary kinase switch control inhibitor platform, inhibit the activation of kinases. DCC-2618, an orally... (more)

Overall

Beta: --
Market Cap(Mil.): $895.53
Shares Outstanding(Mil.): 38.19
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates